This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HMS Holdings Acquires VitreosHealth, Boosts PHM Solution Set
by Zacks Equity Research
HMS Holdings (HMSY) can leverage VitreosHealth's prescriptive health insights that will enhance its growing and lucrative PHM suite.
MDRX vs. HMSY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MDRX vs. HMSY: Which Stock Is the Better Value Option?
Why Is HMS Holdings (HMSY) Up 4.3% Since Last Earnings Report?
by Zacks Equity Research
HMS Holdings (HMSY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Ranked Momentum Stocks to Buy for August 22nd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 22nd
Here's Why You Should Hold on to McKesson (MCK) Stock Now
by Zacks Equity Research
McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.
Here's Why You Should Invest in DaVita (DVA) Stock For Now
by Zacks Equity Research
DaVita (DVA) continues to benefit from international expansion, strategic buyouts and strong demand of dialysis services.
Here's Why You Should Retain Nevro (NVRO) in Your Portfolio
by Zacks Equity Research
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
Here's Why You Should Retain Wright Medical Stock For Now
by Zacks Equity Research
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space. However, forex remains a woe.
HMS Holdings (HMSY) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
HMS Holdings (HMSY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why You Should Invest in Cooper Companies Stock Now
by Zacks Equity Research
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.
Here's Why You Should Invest in HMS Holdings (HMSY) Stock Now
by Zacks Equity Research
HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services as well as robust margins.
SYNH or HMSY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYNH vs. HMSY: Which Stock Is the Better Value Option?
HMS Holdings (HMSY) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Higher revenues, gross margin expansion and raised 2019 outlook benefit HMS Holdings' (HMSY) Q2 earnings.
HMS Holdings (HMSY) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HMS Holdings (HMSY) delivered earnings and revenue surprises of 30.77% and 5.52%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
HMS Holdings (HMSY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
HMS Holdings (HMSY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SYNH vs. HMSY: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYNH vs. HMSY: Which Stock Is the Better Value Option?
Here's Why You Should Retain HMS Holdings (HMSY) Stock
by Zacks Equity Research
HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services. However, stiff competition remains a concern.
Why Is HMS Holdings (HMSY) Up 4.7% Since Last Earnings Report?
by Zacks Equity Research
HMS Holdings (HMSY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HMS Holdings' (HMSY) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Top-line growth, higher commercial and state government revenues and expansion in margins aid HMS Holdings (HMSY) in Q1 earnings. However, increase in cost of services remains a woe.
Huge Employment Report Leads to New Highs for Stocks
by David Borun
Another big employment report ends an eventful week, sending stocks higher
HMS Holdings (HMSY) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
HMS Holdings (HMSY) delivered earnings and revenue surprises of 27.27% and 2.95%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
HMS Holdings (HMSY) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
HMS Holdings (HMSY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bright Near-Term Outlook for Medical Info Systems Industry
by Sweta Jaiswal
The wave of digital transition is helping players in the Zacks Medical Info Systems industry to open up bountiful opportunities for investors.
Why Is HMS Holdings (HMSY) Down 1.2% Since Last Earnings Report?
by Zacks Equity Research
HMS Holdings (HMSY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HMS Holdings Gains on PI & TPM Solutions, Competition Rife
by Zacks Equity Research
HMS Holdings is consistently boosting margins and profitability on product-yield enhancements and process improvements.